Currently, Metagenomi Inc [MGX] is trading at $1.52, up 2.70%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MGX shares have gain 10.14% over the last week, with a monthly amount drifted -11.11%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Metagenomi Inc [NASDAQ: MGX] stock has seen the most recent analyst activity on May 07, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. Previously, JP Morgan downgraded its rating to Neutral on May 02, 2024, and dropped its price target to $6. On March 05, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $25 on the stock. TD Cowen started tracking the stock assigning a Outperform rating. JP Morgan initiated its recommendation with a Overweight and recommended $16 as its price target on March 05, 2024. Jefferies started tracking with a Buy rating for this stock on March 05, 2024, and assigned it a price target of $23. In a note dated March 05, 2024, Chardan Capital Markets initiated an Buy rating and provided a target price of $21 on this stock.
This stock has fluctuated between a low of $1.23 and a high of $8.86 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Metagenomi Inc [NASDAQ: MGX] shares were valued at $1.52 at the most recent close of the market. An investor can expect a potential return of 853.95% based on the average MGX price forecast.
Analyzing the MGX fundamentals
Trailing Twelve Months sales for Metagenomi Inc [NASDAQ:MGX] were 52.30M which represents -22.46% decline. Gross Profit Margin for this corporation currently stands at 0.95% with Operating Profit Margin at -1.7%, Pretax Profit Margin comes in at -1.6%, and Net Profit Margin reading is -1.49%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.3 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4742 points at the first support level, and at 1.4284 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5516, and for the 2nd resistance point, it is at 1.5832.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Metagenomi Inc [NASDAQ:MGX] is 6.91. Also, the Quick Ratio is 6.91, while the Cash Ratio stands at 0.73. Considering the valuation of this stock, the price to sales ratio is 1.09, the price to book ratio is 0.24.
Transactions by insiders
Recent insider trading involved Wein Matthew, that happened on Mar 05 ’25 when 930.0 shares were sold. Chief Financial Officer, Wapnick Pamela completed a deal on Mar 05 ’25 to sell 1808.0 shares. Meanwhile, Chief Financial Officer Wapnick Pamela sold 1559.0 shares on Dec 05 ’24.
